Notizie AIOM – anno XV n. 634

20 Giugno 2017

FDA approves Daratumumab in combination with Pomalidomide and Dexamethasone for relapsed ore refractory multiple Myelomale Myeloma

June 16, 2017 - The U.S. Food and Drug Administration (FDA) has approved the use of daratumumab in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and ...
Leggi tutto

19 Giugno 2017

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

Clinicians and patients often overestimate the benefits of chemotherapy, and overall survival (OS), in platinum resistant/refractory ovarian cancer (PRROC). This study sought to determine aspects of health-related quality of life and clinicopathological characteristics before ...
Leggi tutto

19 Giugno 2017

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

Symptoms are common among patients receiving treatment for advanced cancers, yet are undetected by clinicians up to half the time. There is growing interest in integrating electronic patient-reported outcomes (PROs) into routine oncology practice for symptom monitoring, ...
Leggi tutto

15 Giugno 2017

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population

Recently, tremendous prominence has been given to the investigation of the effect of different research processes as part of the Cancer Moonshot. More than half a century ago, the National Cancer Institute (NCI) established a network of publicly funded cancer cooperative ...
Leggi tutto

15 Giugno 2017

Oncologist Barbara L. McAneny, MD, FASCO, MACP, Elected AMA President-Elect

June 13, 2017 - Physicians gathered at the Annual Meeting of the American Medical Association (AMA) elected Barbara McAneny, MD, FASCO, MACP, an oncologist from Albuquerque, New Mexico, as the new President-Elect of the physicians' organization. Following a year-long term ...
Leggi tutto

15 Giugno 2017

Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties

June 13, 2017 - Last month, I asked my colleagues at the FDA to identify what additional and more forceful steps the FDA can take, on top of the vigorous work the agency is already doing, to address the crisis of opioid addiction. Everyone at the FDA is committed to focusing ...
Leggi tutto

15 Giugno 2017

Early palliative care for adults with advanced cancer

Incurable cancer, which often constitutes an enormous challenge for patients, their families, and medical professionals, profoundly affects the patient's physical and psychosocial well-being. In standard cancer care, palliative measures generally are initiated when it is ...
Leggi tutto

15 Giugno 2017

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

Pulmonary sarcomatoid carcinoma (PSC) is a high-grade NSCLC characterized by poor prognosis and resistance to chemotherapy. Development of targeted therapeutic strategies for PSC has been hampered because of limited and inconsistent molecular characterization. Hybrid capture-based ...
Leggi tutto

15 Giugno 2017

XXXV CONFERENZA NAZIONALE DI CITOMETRIA Aggiornamenti e Innovazioni della Citometria nelle Applicazioni Cliniche e di Ricerca

Paestum (SA), 3 - 6 ottobre 2017 I Soci AIOM potranno usufruire della stessa quota d'iscrizione ridotta per i Soci GIC Bando per il Premio di Studio “Marcello Spanò” GIC 2017, 31^ edizione, dal titolo: “La Citometria nelle tesi sperimentali ed in ...
Leggi tutto

15 Giugno 2017

Premi per incentivare la ricerca di specialisti in Oncologia e Geriatria

Il Gruppo Italiano di Oncologia Geriatrica - GIOGer, istituisce tre premi di 1.000 euro netti ciascuno, che saranno conferiti in occasione del prossimo Congresso nazionale di Oncologia Geriatrica che si terrà a Lecce il 15 e 16 Settembre 2017. Scadenza domande: 30 ...
Leggi tutto

LAVORIAMO CON

News

I dati di follow-up a lungo termine dello studio di fase 3 con mavacamten sottolineano il profilo consolidato di efficacia e sicurezza nei pazienti con cardiomiopatia ipertrofica

BEIGENE ITALIA: ILARIA PIUZZI NUOVO DIRETTORE PUBLIC AFFAIRS, COMUNICAZIONE E PATIENT ADVOCACY

TUMORI: 22 BARCHE A CAPRERA PER IL PROGETTO “PAZIENTI A BORDO”

IN ITALIA 1,7 MILIONI DI PERSONE COLPITE DA MAL DI SCHIENA INFIAMMATORIO

LISTE D’ATTESA, SEBASTIANI (SIR): “PRIMI IMPORTANTI RISULTATI. ORA LO SPECIALISTA REUMATOLOGO”

Alcol, più donne consumatrici e 15% giovani ama il binge drinking

TUMORI: “PER L’84% DEI PAZIENTI MANCA LO PSICONCOLOGO NEL PERCORSO DI CURA”

Notizie AIOM – anno XV n. 634

FDA approves Daratumumab in combination with Pomalidomide and Dexamethasone for relapsed ore refractory multiple Myelomale Myeloma

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population

Oncologist Barbara L. McAneny, MD, FASCO, MACP, Elected AMA President-Elect

Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties

Early palliative care for adults with advanced cancer

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

XXXV CONFERENZA NAZIONALE DI CITOMETRIA Aggiornamenti e Innovazioni della Citometria nelle Applicazioni Cliniche e di Ricerca

Premi per incentivare la ricerca di specialisti in Oncologia e Geriatria